Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for DGWPF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2026 3.640B
March 31, 2026 3.648B
December 31, 2025 3.849B
September 30, 2025 3.562B
June 30, 2025 3.507B
March 31, 2025 3.316B
December 31, 2024 3.296B
September 30, 2024 3.357B
June 30, 2024 3.249B
March 31, 2024 3.272B
December 31, 2023 3.597B
September 30, 2023 3.178B
June 30, 2023 3.247B
March 31, 2023 3.267B
December 31, 2022 3.503B
September 30, 2022 2.915B
June 30, 2022 3.088B
March 31, 2022 3.501B
December 31, 2021 3.710B
September 30, 2021 3.658B
June 30, 2021 3.755B
March 31, 2021 3.745B
December 31, 2020 4.143B
September 30, 2020 3.549B
June 30, 2020 3.257B
Date Value
March 31, 2020 2.952B
December 31, 2019 2.962B
September 30, 2019 2.772B
June 30, 2019 2.812B
March 31, 2019 2.784B
December 31, 2018 2.829B
September 30, 2018 2.659B
June 30, 2018 2.681B
March 31, 2018 2.828B
December 31, 2017 2.906B
September 30, 2017 2.648B
June 30, 2017 2.504B
March 31, 2017 2.423B
December 31, 2016 2.509B
September 30, 2016 2.553B
June 30, 2016 2.515B
March 31, 2016 2.568B
December 31, 2015 2.581B
September 30, 2015 2.480B
June 30, 2015 2.517B
March 31, 2015 2.478B
December 31, 2014 2.836B
September 30, 2014 2.661B
June 30, 2014 2.750B
March 31, 2014 2.806B

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Ottobock SE & Co. KGaA 2.580B
Abbott Laboratories 109.22B
AngioDynamics, Inc. 267.16M
Alphatec Holdings, Inc. 791.03M
AtriCure, Inc. 676.64M

Total Assets (Quarterly) Related Metrics